To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cas No.: | 185243-69-0 |
| pH value: | Corresponds to reference standard： PASS |
| Non-reduced CE-SDS: | 98.4% |
| SEC-HPLC: | 99.1% |
| Isoelectric Point: | Corresponds to reference standard |
| Bacterial Endotoxins Test: | ＜1 EU/ml |
| Exogenous Residual DNA: | ＜1 pg/mg |
| Residual protein A: | ＜1 ng/mg |
| Biological Activity: | Compared with standard, the range ofbiological activity is 111% |
| Osmolality: | Corresponds to reference standard: PASS |
| Peptide mapping: | Corresponds to reference standard: PASS |
| N-terminal sequence: | Corresponds to reference standard:PASS |
| Description: | Etanercept (Enbrel) is a tumor necrosis factor (TNF) inhibitor used for treating rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. |
| Target: | TNF[1] |
| References: | [1]. Burness CB, et al. Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases. BioDrugs. 2016 Aug;30(4):371-8. |